💨 Abstract
There seems to be a mix of two different news stories in the text. Here is a summary of the relevant part: Northwest Biotherapeutics Inc. (NWBO) reported a first-quarter loss of $19.3 million, or 1 cent per share. The cancer drug developer recorded revenue of $375,000 for the period.
Courtesy: wtop.com
Suggested
Charlie Smyth’s game-winner for Saints is ‘dream scenario’ for Northern Irish kicker -
Jakub Dobes stops 27 shots in the Canadiens’ 4-1 victory over the Oilers -
Winning numbers drawn in Sunday’s Virginia Cash Pop -
Jacob Cofie’s 21 points, 10 rebounds help USC beat Washington State 68-61 -
Rams WR Davante Adams might not be ready for Seahawks showdown after reinjuring hamstring vs Lions -
Murphy, Fears lead Pelicans past Bulls 114-104 for second straight win -
Warriors coach Kerr laments shooting at Brown, calls again for common-sense gun control laws -
Two people have been found dead inside a Los Angeles home owned by actor-director Rob Reiner, source tells AP -
2 people found dead in home owned by Rob Reiner, AP source says -
La generación Z impulsa la venta de discos de vinilo, pero la razón no es solo el sonido -